MedicaidPrior AuthMedium impact
Cosela™ (trilaciclib) (Revised)
Humana·OH · Oncology, Hematology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Ohio Medicaid has established new prior authorization requirements for Cosela (trilaciclib) injection, requiring extensive-stage small cell lung cancer diagnosis and specific chemotherapy regimen criteria. This policy becomes effective November 1, 2025 and applies only to Ohio Medicaid patients receiving this cancer treatment.
Action Required
By November 1, 2025: Billing team must update prior authorization procedures for Cosela (trilaciclib) injection for Ohio Medicaid patients. Verify patients have extensive-stage small cell lung cancer diagnosis and are receiving platinum/etoposide or topotecan chemotherapy regimens before administration. Obtain prior authorization through Humana's system or claims will be denied.